Breast cancer imaging with glucosamine CEST (chemical exchange saturation transfer) MRI: first human experience.

Objectives: This study aims to evaluate the feasibility of imaging breast cancer with glucosamine (GlcN) chemical exchange saturation transfer (CEST) MRI technique to distinguish between tumor and surrounding tissue, compared to the conventional MRI method.Methods: Twelve patients with newly diagnos...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 32; no. 11; pp. 7365 - 7374
Autores principales: Rivlin, Michal, Anaby, Debbie, Nissan, Noam, Zaiss, Moritz, Deshmane, Anagha, Navon, Gil, Sklair-Levy, Miri
Formato: diagnostic images research tables/charts Journal Article
Publicado: Springer Nature Nov2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=160256584&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 160256584
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Nov2022
      vid: 32
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        160256584
        160256584
        NLM35420304
        160256584
        10.1007/s00330-022-08772-w
        NLM35420304
        160256584
      ppf: 7365
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Breast cancer imaging with glucosamine CEST (chemical exchange saturation transfer) MRI: first human experience.
      aug:
        au:
          Rivlin, Michal
          Anaby, Debbie
          Nissan, Noam
          Zaiss, Moritz
          Deshmane, Anagha
          Navon, Gil
          Sklair-Levy, Miri
        affil: School of Chemistry, Tel-Aviv University, Levanon St., 6997801, Tel Aviv, Israel
      sug:
        subj:
          Breast Neoplasms Pathology
          Breast Neoplasms
          Magnetic Resonance Imaging Methods
          Middle Age
          Glucosamine
          Prospective Studies
          Algorithms
          Female
          Scales
          Arthritis Impact Measurement Scales
          Middle Aged: 45-64 years
          Female
      ab: Objectives: This study aims to evaluate the feasibility of imaging breast cancer with glucosamine (GlcN) chemical exchange saturation transfer (CEST) MRI technique to distinguish between tumor and surrounding tissue, compared to the conventional MRI method.Methods: Twelve patients with newly diagnosed breast tumors (median age, 53 years) were recruited in this prospective IRB-approved study, between August 2019 and March 2020. Informed consent was obtained from all patients. All MRI measurements were performed on a 3-T clinical MRI scanner. For CEST imaging, a fat-suppressed 3D RF-spoiled gradient echo sequence with saturation pulse train was applied. CEST signals were quantified in the tumor and in the surrounding tissue based on magnetization transfer ratio asymmetry (MTRasym) and a multi-Gaussian fitting.Results: GlcN CEST MRI revealed higher signal intensities in the tumor tissue compared to the surrounding breast tissue (MTRasym effect of 8.12 ± 4.09%, N = 12, p = 2.2 E-03) with the incremental increase due to GlcN uptake of 3.41 ± 0.79% (N = 12, p = 2.2 E-03), which is in line with tumor location as demonstrated by T1W and T2W MRI. GlcN CEST spectra comprise distinct peaks corresponding to proton exchange between free water and hydroxyl and amide/amine groups, and relayed nuclear Overhauser enhancement (NOE) from aliphatic groups, all yielded larger CEST integrals in the tumor tissue after GlcN uptake by an averaged factor of 2.2 ± 1.2 (p = 3.38 E-03), 1.4 ± 0.4 (p =9.88 E-03), and 1.6 ± 0.6 (p = 2.09 E-02), respectively.Conclusion: The results of this initial feasibility study indicate the potential of GlcN CEST MRI to diagnose breast cancer in a clinical setup.Key Points: • GlcN CEST MRI method is demonstrated for its the ability to differentiate between breast tumor lesions and the surrounding tissue, based on the differential accumulation of the GlcN in the tumors. • GlcN CEST imaging may be used to identify metabolic active malignant breast tumors without using a Gd contrast agent. • The GlcN CEST MRI method may be considered for use in a clinical setup for breast cancer detection and should be tested as a complementary method to conventional clinical MRI methods.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N